Actuate Therapeutics

Dallas Biotech Launches Open-Access AI Tool Targeting One of Brain Drug Discovery’s Toughest Hurdles

by | Aug 20, 2025
With just 2% to 6% of small-molecule drugs able to cross the blood-brain barrier, researchers and drugmakers face steep odds. Lantern Pharma’s tool, the company’s CEO says, could be “a paradigm shift” in developing treatments for conditions ranging from brain cancers to Parkinson’s disease.
MORE
Dialectic Therapeutics cancer
Follow the Money: Actuate Therapeutics Raises $11.2M to Fight Cancer, TPG Real Estate Closes $6.8B-plus Fund, Mark Cuban Backs Storage Scholars, and More
by | Oct 24, 2022
In this week’s North Texas deal flow, you’ll also find news about Sinclair Digital Services’ $5 million fundraising effort; Energy Spectrum Capital helping to launch a new energy firm; Darling Ingredients’ $1.2 billion acquisition; the Dallas Cowboys’ official accounting firm merging with BKM Sowan Horan; and more.
MORE
Follow the Money: D.R. Horton Acquires Public Water Resources Firm, Critical Start Raises $215M, Fort Worth Biotech VC Raises New Funds, and More
by | Apr 15, 2022
What companies are finding funding or having a big exit? From startup investments to grants and acquisitions, Dallas Innovates tracks what’s happening in North Texas money.
MORE
funding
Follow the Money: Actuate Raises $6.5M in Series B Funding, Kanarys Raises $1.5M; Topgolf Inks Franchise Deal
by | Nov 14, 2019
In this weekly roundup of funding, merger, and acquisition activity involving companies with North Texas ties, you’ll also find news from Kanarys, Sweat Equities, RSF Partners, Siemens, GoPlant and Align Midstream Partners.
MORE

Follow the Money: InterGen Data Raises $800K in Seed Funding, Nuvei Makes $889M Tech Acquisition

by | May 23, 2019
You’ll also find news about Actuate Therapeutics, Naturally Slim, AmeriTex, Peloton Therapeutics, Stream Energy, and The Crosby Group in this roundup of funding, merger, and acquisition activity involving companies in North Texas.
MORE
Dialectic Therapeutics cancer
Fort Worth Biopharma Actuate Therapeutics Raises $21.7M in Series B Funding
by | May 20, 2019
The company said it will use the funding to expand its ongoing Phase 1 / 2 clinical trial and fund development programs.
MORE
funding
Follow the Money: Select Milk Nets $12M, Actuate Therapeutics Raises $4M, Valify Acquires Tech Firm
by | Sep 20, 2018
From Sunfinity to Forte Payment Systems to Mode Transportation, here are some of the deals involving companies and investors with North Texas ties.
MORE